JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

Clinical trial NCT06586866 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06586866
Sponsor: JenKem Technology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer (TNBC)Brain Metastasases

Start date: 2024-09-26
Primary completion: 2026-05-26
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.